MATWIN is a national programme accelerating early maturation of innovative projects in oncology aiming at maximizing innovation transfer potential. Relying on the existing national ecosystem (canceropoles, SIRIC, technology transfer offices, clusters etc.) and on Unicancer preclinical and clinical network, MATWIN identifies and supports high level oncology research projects with a high development potential. The provided support aims at increasing projects’ industrial attractiveness to boost collaboration opportunities.
Non-French European applicants can apply if they can prove that they have collaboration with French partners (academic team or company).
To apply to MATWIN’s programme, project leaders (academic or start-up) must fill in an application form (downloadable below). Applications are possible all year long. This document will allow MATWIN to have a first view on the project and to refine its positioning.
To benefit from MATWIN 2020-2021 programme’ sessions
and possibly access the MATWIN Board interview,
you must submit your project application form before October 31st 2020.
The pre-selection pitches will take place in Paris in November 2020!
To apply :
The application file presents the project through 3 chapters:
2 Intellectual property
3 Scientific project and development plan
Potential interest of the project will be first assessed by experts involved in the MATWIN process prior being submitted to the opinion of the MATWIN International Board members.
If selected, the project will then be offered an individualized coaching for its possible review by the International Board.
Once interviewed by the MATWIN Board, and upon Board members decision, the best projects may receive a financial support to optimize their development.
Eligibility requirements :
Application should be based on a competitive R&D project and service offers (e.g. CRO services) will be automatically discarded
Scientific quality of the consortium
Original and innovative target or mechanism of action for a product or original marker / biomarker for a diagnostic test
Maturity: to integrate the programme, the project must introduce first scientific evidences demonstrating efficacy of the product (in vitro / in vivo proof of concept, demonstrated mechanism of action, Structure-Activity-Relationship, associated biomarker…) or of the diagnostic test (selectivity, specificity, impact on therapeutic options …);
Strength of intellectual property (if existing). An off-patent innovation may, however, be eligible if protection of the results is being considered
You can download all call for application details and see the FAQ online on this page.
Scientific Director MATWIN
0033 6 84 01 61 70
Depending on the geographical origin of the projects, the discussion around the interest of a MATWIN application may be shared with the representatives of the concerned Canceropôle.